Company / Working Capital
Processa Pharmaceuticals, Inc. Working Capital History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$7.4M
FY2022
5-year range
-$2.4M / $17.4M
FY2018-FY2022
Trend
-57.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 6 years, ranging from -$2M in FY2016 to $17M in FY2021.
Based on SEC 10-K filings.
$7M in FY2022.
Improved from -$2M to $7M over the past 6 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, working capital decreased 57.4% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $7.4M | -57.4% |
| FY2021 | $17.4M | +838.2% |
| FY2016 | -$2.4M | -18.8% |
| FY2015 | -$2.0M | -329.4% |
| FY2014 | -$460.8K | +24.1% |
| FY2013 | -$607.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026